Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First
Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board
Meeting. The results will be available on the Company's website www.drreddys.com.
Summary of Events
Email, Media, Company website, Business Wire
URL available on Company's website, www.drreddys.com
Following the release, the management of the Company will host an
earnings call to discuss the Company's financial performance.
Accessible from all major carriers except BSNL/MTNL.
Available in Ahmedabad, Bangalore, Chandigarh, Chennai,
Kochi/Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune
Accessible from all carriers.
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448
No password/pin number is necessary to dial in to any of the other
calls. As participation in the call is limited, early registration is
encouraged. The operator will provide instructions on asking questions
before and during the call.
The audio webcast of the earnings call will be available to all
interested parties at www.drreddys.com.
Please visit the web site at least fifteen minutes ahead of the
scheduled start time to register and to download and install any
necessary audio software. Participants in the webcast can listen to the
proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through August 4th, 2014. For
play back dial in phone No: 022 3065 1212 and ID: 375#.
The transcript of the earnings call will also be available on the
About Dr. Reddy's
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses -
Pharmaceutical Services and Active Ingredients, Global Generics and
Proprietary Products - Dr. Reddy's offers a portfolio of products and
services including APIs, custom pharmaceutical services, generics,
biosimilars and differentiated formulations. Major therapeutic focus is
on gastro-intestinal, cardiovascular, diabetology, oncology, pain
management and anti-infective. Major markets include India, USA,
Russia-CIS and Europe apart from other select geographies within
For more information, log on to: www.drreddys.com
*EDT- Eastern Daylight Saving Time
[ Back To NFVZone's Homepage ]